UB Paderborn / Katalog / Suche / in CDI

Inhibition of Antiestrogen-Promoted Pro-Survival Autophagy and Tamoxifen Resistance in Breast Cancer through Vitamin D Receptor

Nutrients, 2021-05, Vol.13 (5), p.1715

2021

Link zum Volltext

Verfügbarkeit prüfen

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling

Oncogene, 2003-10, Vol.22 (47), p.7316-7339

2003

Link zum Volltext

Verfügbarkeit prüfen

Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13), p.3607-3620

2021

Link zum Volltext

Verfügbarkeit prüfen

USP13 promotes development and metastasis of high-grade serous ovarian carcinoma in a novel mouse model

Oncogene, 2022-03, Vol.41 (13), p.1974-1985

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model

JNCI : Journal of the National Cancer Institute, 2017-01, Vol.109 (1), p.djw188

2017

Link zum Volltext

Verfügbarkeit prüfen

The RhoA-binding protein, Rhophilin-2, Regulates Actin Cytoskeleton Organization

The Journal of biological chemistry, 2002-11, Vol.277 (46), p.43924-43932

2002

Link zum Volltext

Verfügbarkeit prüfen

Social isolation induces autophagy in the mouse mammary gland: link to increased mammary cancer risk

Endocrine-related cancer, 2016-10, Vol.23 (10), p.839-856

2016

Link zum Volltext

Verfügbarkeit prüfen

Genistein: Does It Prevent or Promote Breast Cancer?

Environmental health perspectives, 2000-08, Vol.108 (8), p.701-708

2000

Link zum Volltext

Verfügbarkeit prüfen

Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis

Carcinogenesis (New York), 2005-09, Vol.26 (9), p.1527-1535

2005

Link zum Volltext

Verfügbarkeit prüfen

Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance

Carcinogenesis (New York), 2015-01, Vol.36 (1), p.122-132

2015

Link zum Volltext

Verfügbarkeit prüfen

Exposure to Excess Estradiol or Leptin during Pregnancy Increases Mammary Cancer Risk and Prevents Parity-Induced Protective Genomic Changes in Rats

Cancer prevention research (Philadelphia, Pa.), 2013-11, Vol.6 (11), p.1194-1211

2013

Link zum Volltext

Verfügbarkeit prüfen

Interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant)

Cancer research (Chicago, Ill.), 2004-06, Vol.64 (11), p.4030-4039

2004

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4311: Targeting specific regulatory subunits of protein phosphatase 1 phenocopies estrogen-induced apoptosis

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4311-4311

2017

Link zum Volltext

Verfügbarkeit prüfen

Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-κB, and cyclic AMP response element binding with acquired resistance to faslodex (ICI 182,780)

Cancer research (Chicago, Ill.), 2002-06, Vol.62 (12), p.3428-3437

2002

Link zum Volltext

Verfügbarkeit prüfen

Targeting DDX3X triggers anti-tumor immunity via a dsRNA-mediated tumor-intrinsic type I interferon response

Cancer research (Chicago, Ill.), 2021-05, Vol.81 (13), p.3607-3620

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular and pharmacological aspects of antiestrogen resistance

Journal of steroid biochemistry and molecular biology, 2001-01, Vol.76 (1), p.71-84

2001

Link zum Volltext

Verfügbarkeit prüfen

Antiestrogen resistance and the application of systems biology

Drug discovery today. Disease mechanisms, 2012-01, Vol.9 (1-2), p.e11-e17

2012

Link zum Volltext

Verfügbarkeit prüfen

Do estrogens always increase breast cancer risk?

The Journal of steroid biochemistry and molecular biology, 2002-02, Vol.80 (2), p.163-174

2002

Link zum Volltext

Verfügbarkeit prüfen

Does p53 status influence tumor response to anticancer therapies?

Anti-cancer drugs, 2000-07, Vol.11 (6), p.419-432

2000

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1027: Autophagy as a mediator of increased mammary cancer risk in socially isolated mice

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1027-1027

2016

Link zum Volltext

Verfügbarkeit prüfen

Interaction of dietary polyphenols with molecular signaling pathways of antiestrogen resistance: possible role in breast cancer recurrence

Hormone molecular biology and clinical investigation, 2012-04, Vol.9 (2), p.127-141

2012

Link zum Volltext

Verfügbarkeit prüfen

The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines

Cancer genetics and cytogenetics, 2007-05, Vol.175 (1), p.61-64

2007

Link zum Volltext

Verfügbarkeit prüfen

Do estrogens always increase breast cancer risk?: Proliferation of normal and malignant mammary epithelial cells

The Journal of steroid biochemistry and molecular biology, 2002, Vol.80 (2), p.163-174

2002

Link zum Volltext

Verfügbarkeit prüfen

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling: Drug Resistance

Oncogene, 2003, Vol.22 (47), p.7316-7339

2003

Link zum Volltext

Verfügbarkeit prüfen

Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780)

Cancer research (Chicago, Ill.), 2002-06, Vol.62 (12), p.3428-3437

2002

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Inhibition of Antiestrogen-Promoted Pro-Survival Autophagy and Tamoxifen Resistance in Breast Cancer through Vitamin D Receptor

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling

Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response

USP13 promotes development and metastasis of high-grade serous ovarian carcinoma in a novel mouse model

Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model

The RhoA-binding protein, Rhophilin-2, Regulates Actin Cytoskeleton Organization

Social isolation induces autophagy in the mouse mammary gland: link to increased mammary cancer risk

Genistein: Does It Prevent or Promote Breast Cancer?

Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis

Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance

Exposure to Excess Estradiol or Leptin during Pregnancy Increases Mammary Cancer Risk and Prevents Parity-Induced Protective Genomic Changes in Rats

Interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant)

Abstract 4311: Targeting specific regulatory subunits of protein phosphatase 1 phenocopies estrogen-induced apoptosis

Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-κB, and cyclic AMP response element binding with acquired resistance to faslodex (ICI 182,780)

Targeting DDX3X triggers anti-tumor immunity via a dsRNA-mediated tumor-intrinsic type I interferon response

Molecular and pharmacological aspects of antiestrogen resistance

Antiestrogen resistance and the application of systems biology

Do estrogens always increase breast cancer risk?

Does p53 status influence tumor response to anticancer therapies?

Abstract 1027: Autophagy as a mediator of increased mammary cancer risk in socially isolated mice

Interaction of dietary polyphenols with molecular signaling pathways of antiestrogen resistance: possible role in breast cancer recurrence

The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines

Do estrogens always increase breast cancer risk?: Proliferation of normal and malignant mammary epithelial cells

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling: Drug Resistance

Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780)

Suchergebnisse filtern